A structured self-assessment of your institution's AML/CFT programme readiness against the GIABA Immediate Outcome framework. Six domains. Twenty-two questions. Approximately 8 minutes.
About this assessment: This tool is calibrated to the supervisory examination standard used by GIABA assessors and BoG examiners — aligned to Act 1044, the BoG/FIC Guideline 2025, and GIABA Immediate Outcomes IO.3, IO.4, and IO.6. It is not a regulatory examination or audit. It is an indicative diagnostic to help your institution identify priority gaps before the November 2026 GIABA Plenary deadline.
Section 1 of 60% complete
Section 1 — Board & Governance
Board oversight and AMLRO governance
Aligned to BoG/FIC Guideline 2025 Board accountability requirements and Act 1044 s.48 personal liability provisions.
Section 2 — Enterprise-Wide Risk Assessment
EWRA quality and NRA alignment
Aligned to BoG/FIC Guideline 2025 §2.2 and GIABA IO.4 — the examiner's primary evidence test for risk-based programme design.
Section 3 — Customer Due Diligence
CDD, EDD, and beneficial ownership
Aligned to Act 1044 ss.15–17, BoG/FIC Guideline 2025 §§2.4–2.5, and the 5% BO threshold under §2.4.2(12).
Suspicion identification, STR quality, and TM calibration
Aligned to Act 1044 s.38(1) 24-hour STR clock, GIABA IO.6, and BoG/FIC Guideline 2025 §2.6.
Section 5 — Sanctions & PEP Screening
Screening coverage, calibration, and data quality
Aligned to BoG/FIC Guideline 2025 §2.7 and GIABA IO.4 screening effectiveness standard.
Section 6 — Training, Culture & Documentation
Staff competency, programme evidence, and record-keeping
Aligned to BoG/FIC Guideline 2025 §§2.9–2.12 and GIABA IO.3 supervisory effectiveness standard.
Please answer all questions before continuing.
Your Assessment Results
Domain-by-domain readiness
Discuss your results with RegBridge
A 30-minute conversation — no commitment, no pitch. We will review your assessment results, identify your highest-priority gaps, and recommend the products and services most suited to your position.